New Zealand markets closed

JiangXi Tianxin Pharmaceutical Co., Ltd. (603235.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
24.77+0.21 (+0.86%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,798,375
1,881,993
2,304,791
2,522,434
2,303,590
Cost of revenue
1,062,091
1,161,709
1,446,825
1,431,467
1,053,209
Gross profit
736,285
720,284
857,966
1,090,967
1,250,381
Operating expenses
Research development
118,672
111,965
89,463
58,940
49,362
Selling general and administrative
74,952
81,954
88,317
75,741
69,503
Total operating expenses
247,857
253,363
232,878
163,738
118,493
Operating income or loss
488,428
466,921
625,088
927,230
1,131,888
Interest expense
-
2,100
6,928
12,671
13,059
Income before tax
610,255
565,170
725,758
873,374
1,046,733
Income tax expense
95,451
89,316
103,643
129,487
159,644
Income from continuing operations
514,804
475,853
622,115
743,887
887,089
Net income
514,804
475,853
622,115
743,887
887,089
Net income available to common shareholders
514,804
475,853
622,115
743,887
887,089
Basic EPS
1.08
1.09
1.51
1.89
2.25
Diluted EPS
1.08
1.09
1.51
1.89
2.25
Basic average shares
439,699
436,563
411,997
393,591
394,262
Diluted average shares
439,699
436,563
411,997
393,591
394,262